Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.
McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall HS, Estcourt MJ, Wadia U, Tjiam MC, Blyth CC, Subbarao K, Mordant FL, Nicholson S, Cain N, Brizuela R, Faust SN, Thornton RB, Ellis Z, Mckenzie A, Marsh JA, Snelling TL, Richmond PC. McLeod C, et al. Among authors: marsh ja. J Infect. 2024 Nov 14:106346. doi: 10.1016/j.jinf.2024.106346. Online ahead of print. J Infect. 2024. PMID: 39550007
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanoma.
Lu Y, Travnickova J, Badonyi M, Rambow F, Coates A, Khan Z, Marques J, Murphy LC, Garcia-Martinez P, Marais R, Louphrasitthiphol P, Chan AHY, Schofield CJ, von Kriegsheim A, Marsh JA, Pavet V, Sansom OJ, Illingworth RS, Patton EE. Lu Y, et al. Among authors: marsh ja. Cell Rep. 2024 Nov 14;43(11):114927. doi: 10.1016/j.celrep.2024.114927. Online ahead of print. Cell Rep. 2024. PMID: 39546399 Free article. No abstract available.
Curating genomic disease-gene relationships with Gene2Phenotype (G2P).
Yates TM, Ansari M, Thompson L, Hunt SE, Uhalte EC, Hobson RJ, Marsh JA, Wright CF, Firth HV. Yates TM, et al. Among authors: marsh ja. Genome Med. 2024 Nov 6;16(1):127. doi: 10.1186/s13073-024-01398-1. Genome Med. 2024. PMID: 39506859 Free PMC article.
MDA5 gain-of-function associated with a Glu794del mutation.
Wong C, Gerasimavicius L, Crow YJ, Uggenti C; E794del consortium. Wong C, et al. J Clin Immunol. 2024 Oct 2;45(1):20. doi: 10.1007/s10875-024-01813-7. J Clin Immunol. 2024. PMID: 39356338 Free PMC article. No abstract available.
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.
McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall H, Estcourt MJ, Tjiam MC, Blyth CC, Subbarao K, Mordant FL, Nicholson S, Faust SN, Wadia U, Thornton RB, Ellis Z, Mckenzie A, Marsh JA, Snelling TL, Richmond P. McLeod C, et al. Among authors: marsh ja. J Infect. 2024 Sep 26;89(6):106286. doi: 10.1016/j.jinf.2024.106286. Online ahead of print. J Infect. 2024. PMID: 39341401 Free article.
257 results